Novo Nordisk 

Compound Sharing

Novo Nordisk 

Compound Sharing


Driving innovation through sharing

To accelerate innovation, Novo Nordisk openly shares novel peptide and protein analogues as well as antibodies for preclinical research.

Through this open innovation initiative, we offer easy and free access to selected high-quality and well-characterized compounds to curious and passionate scientists from around the world. We hope that sharing can advance the research of those who want to discover new mode of action and expand disease biology understanding, which can ultimately contribute to accelerating future breakthroughs for medical solutions.

The process and criteria are simple and transparent - we provide the compounds for free for you to validate your scientific hypothesis, you own the results and are encouraged to publish these. There is no reporting required but if you obtain exciting new results, you are welcome to get in touch for a discussion of the data and the possibilities for a future collaboration.

For COVID-19 related compounds, please contact Department Manager Theresa Bak-Thomsen,

Available compounds

Explore and learn more about our compounds

Long-acting a-MSH analogue


Read more

Long-acting amylin analogue


Read more

Long-acting CCK analogue


Read more

Long-acting GLP-1 analogue #1


Read more

Long-acting GLP-1 analogue #2


Read more

Long-acting GLP-2 analogue


Read more

Long-acting glucagon analogue


Read more

Partial glucagonR agonist


Read more

Small molecule glucagonR antagonist


Read more

Long-acting insulin analogue


Read more

Liver-preferential insulin analogue


Read more

InsR peptide antagonist (S961)


Read more

PYY analogue - Y2 selective


Read more

Long-acting PYY analogue

Coming soon

Read more

Anti-InsR mAb G6


Read more

Anti-GLP-1R antibodies

mAb clone 7F38 and 3F52

Read more

Anti-IGF1R mAb 226


Read more



About Novo Nordisk Compound Sharing

Watch the video below to learn more about Novo Nordisk Compound Sharing


If you have questions or comments in relation to Compound Sharing do not hesitate to contact us. You are also welcome to take a look at the FAQs.

You can reach us at – we are looking forward to answering your questions.


Tine Glendorf and Lars Linderoth
Scientists from the Novo Nordisk Compound Sharing team

Stay updated 

Be the first to know when we add new compounds to the site or stories related to how our compounds are being used in the scientific community 


Yes, I consent to receive Compound Sharing Updates from Novo Nordisk
I accept to have read and understood Novo Nordisk’s privacy notice. 
success icon Thank you for subscribing!
success icon

Careers in R&D



We are looking for scientific talent to join us. If you are interested in joining our research and development teams, explore your opportunities at our careers page.  

View R&D jobs



Partnering opportunities



Interested in partnering with Novo Nordisk? We constantly seek innovative alliances with academic and healthcare institutions, as well as leading biotechnology and pharmaceutical companies.

Partner with us